Advertisement
Advertisement
HELP
Cybin Inc. Common Stock
11.61
USDSponsored
+0.51
+4.59%
Aug 07, 15:59 UTC -4
Closed
After-Market
11.59
-0.02
-0.14%
HELP Earnings Reports
Positive Surprise Ratio
HELP beat 0 of 3 last estimates.
0%
Next Report
Date of Next Report
Nov 11, 2026
Estimate for Q2 27 (Revenue/ EPS)
--
/-$1.03
Implied change from Q1 27 (Revenue/ EPS)
--
/--
Implied change from Q2 26 (Revenue/ EPS)
--
/-36.42%
Cybin Inc. Common Stock earnings per share and revenue
On Aug 06, 2026, HELP reported earnings of -- USD per share (EPS) for Q1 27, -- the estimate of -0.97 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference.
Looking ahead to Q2 27, 4 analysts forecast an EPS of -1.03 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Ardelyx, Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.05
Actual
-$0.07
Surprise
-18.85%
Collegium Pharmaceutical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
$1.74
Actual
$1.92
Surprise
+9.75%
Cronos Group Inc. Common Share
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.00
Actual
$0.03
Surprise
0.00%
Ironwood Pharmaceuticals, Inc. - Class A
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.36
Actual
$0.31
Surprise
-14.62%
Relmada Therapeutics, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.20
Actual
-$0.11
Surprise
+45.95%
Organogenesis Holdings Inc. Class A Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.35
Actual
-$0.71
Surprise
-98.88%
Avita Medical, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.29
Actual
-$0.25
Surprise
+14.50%
electroCore, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.43
Actual
-$0.33
Surprise
+23.40%
Definium Therapeutics, Inc. Common Shares
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.55
Actual
-$1.44
Surprise
-158.25%
Amylyx Pharmaceuticals, Inc. Common Stock
Report Date
Aug 06, 2026 For Q2 26
Estimate
-$0.36
Actual
-$0.39
Surprise
-5.95%
FAQ
What were Cybin Inc. Common Stock's earnings and revenue for the latest quarter Q1 2027?
For Q1 2027, Cybin Inc. Common Stock reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Cybin Inc. Common Stock's Q1 2027 earnings?
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
When is Cybin Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 11, 2026.
What are the forecasts for Cybin Inc. Common Stock's next earnings report?
Based on 4
analysts, Cybin Inc. Common Stock is expected to report EPS of -$1.03 and revenue of -- for Q2 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement